Tau Therapeutics Academic Collaborator Roger Abounader Wins Grant

... funded through the CIT this year," said Andrew Krouse, President and CEO of Tau Therapeutics. "His cancer stem cell research is critical to finding innovative therapies for brain cancer patients." Dr. Abounader's work focuses on glioblastoma, the ...

http://www.businesswire.com/news/topix/20130819005159/en